AMGEN TO PRESENT AT THE 2025 WELLS FARGO HEALTHCARE CONFERENCE
Amgen (NASDAQ:AMGN) announced its upcoming participation in the 2025 Wells Fargo Healthcare Conference.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Amgen (NASDAQ:AMGN) announced its upcoming participation in the 2025 Wells Fargo Healthcare Conference. The presentation will take place on Wednesday, September 3, 2025, at 10:15 a.m. ET. Dr. Paul Burton, the company's Senior Vice President and Chief Medical Officer, will represent Amgen at the conference.
The presentation will be accessible via webcast on Amgen's website under the Investors section, with the recording remaining available for replay for at least 90 days following the event.
Details
News Market Reaction – AMGN
On Sep 2, the first trading day after this news, AMGN closed 0.27% below the previous close.
Data tracked by StockTitan Argus for the Sep 2 session.
AI-generated analysis. How Rhea-AI works. Not financial advice.
The webcast, as with other selected presentations regarding developments in Amgen's business given by management at certain investor and medical conferences, can be found on Amgen's website, www.amgen.com, under Investors. Information regarding presentation times, webcast availability and webcast links are noted on Amgen's Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 90 days after the event.
About Amgen
Amgen discovers, develops, manufactures and delivers innovative medicines to help millions of patients in their fight against some of the world's toughest diseases. More than 40 years ago, Amgen helped to establish the biotechnology industry and remains on the cutting-edge of innovation, using technology and human genetic data to push beyond what's known today. Amgen is advancing a broad and deep pipeline that builds on its existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases.
In 2024, Amgen was named one of the "World's Most Innovative Companies" by Fast Company and one of "America's Best Large Employers" by
For more information, visit Amgen.com and follow us on X (formerly known as Twitter), LinkedIn, Instagram, YouTube and Threads.
CONTACT: Amgen,
Elissa Snook, 609-251-1407 (media)
Adam Elinoff, 805-490-9578 (investors)
View original content to download multimedia:https://www.prnewswire.com/news-releases/amgen-to-present-at-the-2025-wells-fargo-healthcare-conference-302542159.html
SOURCE Amgen
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.